01:11:00
Immunocine Conference Compilation
07:46
Life After Cancer | Brian's Terminal Bladder Cancer
03:34
Meet the Team Transforming Cancer Care | Immunocine Cancer Center
06:42
Kidney Cancer Survivor Story | Justin at Immunocine Cancer Center
08:48
Cancer Education & Immunotherapy Key Facts | FAQ EP4 of 4
04:06
Learn About How Immunocine Started & Why | FAQ EP3 of 4
05:29
How to Become an Immunocine Patient | FAQ EP2 of 4
12:24
Learn How Our Treatment Works | FAQ EP1 of 4
09:23
Life After Cancer | Kevinās Fight Against Melanoma Cancer
05:47
Breakthrough Cancer Immunotherapy | Immunocine Cancer Center
06:13
Prostate Cancer Survivor Story | Martin at Immunocine Cancer Center
01:31
Welcome to the Future of Cancer Treatment | Immunocine Cancer Center
05:49
Life After Cancer | Babette's Journey with Stage 4 Ovarian Cancer
05:31
Pancreatic Cancer Survivor Story | Al at Immunocine Cancer Center
00:35
Brock S. (Stage 4 Melanoma) Highlight
07:34
Melanoma Cancer Survivor Story | Brock at Immunocine Cancer Center
04:52
Breast Cancer Survivor Story | Lynn at Immunocine Cancer Center
04:41
Cancer Survivor Story | Kareema at Immunocine Cancer Center
06:31
Breast Cancer Survivor Story | Sheryl at Immunocine Cancer Center
05:58
Prostate Cancer Survivor Story | Chris at Immunocine Cancer Center
X
About
Your Greatest Defense is Within You
Immunocine was founded with the sole purpose of bringing a revolutionary immunotherapy to cancer patients unable to participate in ongoing FDA clinical trials.
The Immunocine Dendritic Cell Treatment (IDCT) protocol is the first to āDouble Loadā the patientās Dendritic Cells with their extracted cancer cells. This simulates a viral-like infection and initiates specific T cells to seek and destroy the cancer cells throughout the patientās body.
Backed by 16 years of research and ongoing FDA Clinical Trials, the IDCT protocol is a less invasive, more precise way to treat multiple types of cancer.
Visit our website to see if you are eligible to apply for treatment.
Tags